Home » Health » Pfizer offers to send Covid-19 vaccines to the states in April: Governor of Querétaro

Pfizer offers to send Covid-19 vaccines to the states in April: Governor of Querétaro

The governor of Queretaro, Francisco Dominguez, commented this Saturday that the pharmaceutical company Pfizer could send doses of your Covid-19 vaccine to the states starting in April, but authorization from the federal government.

“If we add ourselves to the macro contract of the federal government, to be able to gather a purchase stock of 20 million vaccines (…). Pfizer mentions that he could give us a million and a half vaccines in April, seven million vaccinations in June and, from July to December, the rest. However, we need the signature of the Health Secretary federal, ”he said Dominguez at the meeting of the Association of Governors of the National Action Party (GOAN).

We recommend you read: Next week they will vaccinate against Covid the older adults who were absent in CDMX

The governor of Queretaro commented that, during the meeting of the National Conference of Governors (Conago) last Thursday, the state leaders discussed the issue with the Secretary of Health, Jorge Alcocer Varela, and the Undersecretary of Prevention and Health Promotion, Hugo Lopez-Gatell, but they did not reach an agreement.

“We are going to continue insisting because what we want is to help immunize all our entities faster. This is not politics, nor are we going to do electoral use from vaccine. We want to help the federal government to immunize our populations very quickly in the states, “he added. Francisco.

The vaccine Pfizer against Covid-19 was the first to be approved for her emergency use in Mexico, in December of last year. It applies to medical personnel caring for coronavirus patients.

Do not miss: Only the first dose of Pfizer’s vaccine against Covid is 85% effective, study reveals

Yesterday, a study conducted at the Sheba Medical Center, located in Israel, showed that the first dose from vaccine of Pfizer against Covid-19 it is 85% effective in people with symptoms of the disease. This percentage falls to 75% if asymptomatic patients are considered.

According to the analysis, published in the magazine The Lancet, this percentage of effectiveness was detected two weeks after the application of the first dose from vaccine.

According to him study, these data allow us to conclude that it is possible to delay the administration of the second dose of this vaccine in countries experiencing shortages. Thus, more people can be inoculated for the first time.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.